about
Melanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyDendritic cell-based vaccine efficacy: aiming for hot spotsCancer immunotherapy via dendritic cellssiRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study.Trial watch: Dendritic cell-based interventions for cancer therapyRobust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.An outsider's perspective--ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells.Recent developments in cancer vaccinesTargeting the tumor microenvironment by immunotherapy: part 2.PMA withdrawal in PMA-treated monocytic THP-1 cells and subsequent retinoic acid stimulation, modulate induction of apoptosis and appearance of dendritic cells.Immunotherapy of cancers comes of age.Dendritic cells based immunotherapy.Generation of myeloid-derived suppressor cells using prostaglandin E2.Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine.Stem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis
P2860
Q26798404-8CF580F0-69A2-494B-B2B0-B41F926B4548Q28082680-DE210117-BDB4-469B-A16B-97E1E9D01C94Q29615444-96B18BEF-4FCB-474F-838B-4BAC4DDED3B5Q35546869-91D434CD-C484-44EC-8BB1-4236015C4218Q35553327-C39CCE7E-6A1D-46FE-8555-0B47FC06EC98Q36038020-344B5C09-9659-4D3B-86DE-8BF474645A8FQ36388529-0372B4D2-86A7-4672-990F-528E88B71E25Q36654119-2E7E4527-04B9-4F65-9A99-6C218C8640DAQ37823363-6523C402-C78B-4A3B-AEF1-251F48505C2AQ37830226-AADDE2D8-21E7-4CFC-8F6B-9087CCCA38BFQ37952796-02A3BBF5-D40C-40F5-80D6-2CB0FDA3F77BQ39149224-1FB341F8-79EA-441E-A82D-BFC34DA3717DQ40099075-4B8B66FA-3C2B-4956-B393-3F94B864C913Q43043935-2F83E988-088D-4AA3-90CF-BA03F19AE4CAQ43110927-8D623824-D1EF-4BF6-A28C-97B635366B9DQ53415023-8D6C6DBA-4A60-4C74-B5C0-71967ACA90ABQ58199154-B969C6D8-418E-4C67-9937-FE2781F997A5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendritic cells: are they clinically relevant?
@en
Dendritic cells: are they clinically relevant?
@nl
type
label
Dendritic cells: are they clinically relevant?
@en
Dendritic cells: are they clinically relevant?
@nl
prefLabel
Dendritic cells: are they clinically relevant?
@en
Dendritic cells: are they clinically relevant?
@nl
P2093
P2860
P1433
P1476
Dendritic cells: are they clinically relevant?
@en
P2093
Joseph Fay
Karolina Palucka
Lee Roberts
P2860
P304
P356
10.1097/PPO.0B013E3181EACA83
P577
2010-07-01T00:00:00Z